Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Adenocarcinoma · Cholangiocarcinoma · Lung Cancer · Stomach Cancer · Esophageal Carcinoma · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tongji Hospital, Wuhan, Hubei, China
Contact: Study coordinator (Liu Huang) · huangliu@tjh.tjmu.edu.cn · 63639656

Study leads

Xianglin Yuan
Principal Investigator
Tongji Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Adenocarcinoma · Carcinoma · Neoplasms

Abroad (travel likely)Recruiting

Béthune, France · Bordeaux, France

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Prostate Cancer Castration-resistant Prostate Cancer · Breast Cancer · Colo-rectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States · Grand Rapids, United States

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States